Business Context and Reporting Period
This Form 8-K is a current report filed by ReWalk Robotics Ltd. (noting the input metadata reference to "Lifeward Ltd." appears to be an error as the filing explicitly names ReWalk Robotics) on May 26, 2022. The report pertains to the filing of a revised preliminary proxy statement with the SEC in connection with the Company's 2022 Annual Meeting of Shareholders.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a disclosure of corporate governance activities rather than a financial performance report.
Material Changes
The primary material event reported is the submission of a revised preliminary proxy statement and the issuance of a letter from the Board of Directors to shareholders regarding the 2022 Annual Meeting. No financial changes versus prior periods are disclosed in this specific filing.
Guidance, Outlook, and Risks
- Management Commentary: The Board of Directors issued a letter to shareholders, the full text of which is included in the press release furnished as Exhibit 99.1.
- Regulatory Disclosure: The Company, its directors, and certain executive officers are participants in the solicitation of proxies. Shareholders are strongly encouraged to read the definitive proxy statement and accompanying materials when available.
- Information Availability: Details regarding director and officer security holdings are available in Forms 3, 4, and 5, as well as the 2021 Form 10-K and its Amendment No. 1.
Investor Verification Checklist
- Verify the contents of the revised preliminary proxy statement and the Board of Directors' letter referenced in Exhibit 99.1.
- Review the definitive proxy statement once filed to understand the specific proposals for the 2022 Annual Meeting.
- Check the Company's website (http://ir.rewalk.com) or the SEC website for the latest Forms 3, 4, and 5 regarding changes in director and officer holdings.
- Confirm the date and agenda of the 2022 Annual Meeting of Shareholders.